For patients on semaglutide who are concerned about losing strength, adding peptide therapy creates a dual approach: GLP-1 medications drive appetite control and fat reduction, while peptides support the anabolic environment muscles need to stay intact
Controlled and uncontrolled studies using folinic acid, a reduced form of folate, have reported marked improvements in core and associated ASD symptoms in some children with ASD and folate related pathway abnormities
In a recent review published in the Journal of Clinical and Translational Hepatology , researchers explore the therapeutic potential and clinical insights of glucagon-like peptide-1 receptor agonists (GLP-1RAs) in the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
Since embarking on the petition to make B12 OTC, some have commented that they fear that GPs might stop giving B12 altogether if successful
Because the effect is centrally mediated (originating in the brain), it can complement other therapies for sexual performance without relying solely on vascular stimulation
